Cerus Corporation (CERS)
USD 1.21
(-6.2%)
USD 1.21
(-6.2%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 156.36 Million USD | -3.51% |
| 2022 | 162.04 Million USD | 23.83% |
| 2021 | 130.85 Million USD | 42.36% |
| 2020 | 91.92 Million USD | 23.14% |
| 2019 | 74.64 Million USD | 22.56% |
| 2018 | 60.9 Million USD | 39.8% |
| 2017 | 43.56 Million USD | 17.17% |
| 2016 | 37.18 Million USD | 8.65% |
| 2015 | 34.22 Million USD | -6.25% |
| 2014 | 36.5 Million USD | -7.95% |
| 2013 | 39.65 Million USD | 8.07% |
| 2012 | 36.69 Million USD | 11.05% |
| 2011 | 33.04 Million USD | 42.99% |
| 2010 | 23.1 Million USD | 28.51% |
| 2009 | 17.98 Million USD | 8.94% |
| 2008 | 16.5 Million USD | 49.47% |
| 2007 | 11.04 Million USD | -68.96% |
| 2006 | 35.58 Million USD | 45.99% |
| 2005 | 24.37 Million USD | 75.19% |
| 2004 | 13.91 Million USD | 43.93% |
| 2003 | 9.66 Million USD | 13.84% |
| 2002 | 8.49 Million USD | 87.21% |
| 2001 | 4.53 Million USD | 145.0% |
| 2000 | 1.85 Million USD | -22.88% |
| 1999 | 2.4 Million USD | -17.24% |
| 1998 | 2.9 Million USD | -57.97% |
| 1997 | 6.9 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 38.36 Million USD | -17.97% |
| 2024 Q3 | 46.01 Million USD | 2.08% |
| 2024 Q2 | 45.07 Million USD | 17.5% |
| 2023 Q4 | 46.76 Million USD | 17.59% |
| 2023 Q1 | 30.97 Million USD | -29.66% |
| 2023 FY | 156.36 Million USD | -3.51% |
| 2023 Q2 | 38.85 Million USD | 25.44% |
| 2023 Q3 | 39.77 Million USD | 2.37% |
| 2022 Q4 | 44.03 Million USD | 11.28% |
| 2022 FY | 162.04 Million USD | 23.83% |
| 2022 Q2 | 40.99 Million USD | 9.49% |
| 2022 Q3 | 39.57 Million USD | -3.48% |
| 2022 Q1 | 37.44 Million USD | -6.07% |
| 2021 Q2 | 31.48 Million USD | 34.67% |
| 2021 FY | 130.85 Million USD | 42.36% |
| 2021 Q4 | 39.86 Million USD | 10.33% |
| 2021 Q3 | 36.13 Million USD | 14.76% |
| 2021 Q1 | 23.37 Million USD | -17.09% |
| 2020 Q4 | 28.19 Million USD | 19.45% |
| 2020 Q2 | 21.5 Million USD | 15.54% |
| 2020 Q3 | 23.6 Million USD | 9.78% |
| 2020 FY | 91.92 Million USD | 23.14% |
| 2020 Q1 | 18.61 Million USD | -11.02% |
| 2019 Q4 | 20.91 Million USD | 16.08% |
| 2019 Q1 | 17.5 Million USD | 5.92% |
| 2019 FY | 74.64 Million USD | 22.56% |
| 2019 Q2 | 18.2 Million USD | 4.03% |
| 2019 Q3 | 18.01 Million USD | -1.04% |
| 2018 Q3 | 15.39 Million USD | -0.14% |
| 2018 Q2 | 15.42 Million USD | 13.68% |
| 2018 Q4 | 16.52 Million USD | 7.31% |
| 2018 Q1 | 13.56 Million USD | -16.48% |
| 2018 FY | 60.9 Million USD | 39.8% |
| 2017 Q2 | 9.52 Million USD | 35.95% |
| 2017 Q1 | 7 Million USD | -30.8% |
| 2017 Q3 | 10.79 Million USD | 13.35% |
| 2017 Q4 | 16.24 Million USD | 50.41% |
| 2017 FY | 43.56 Million USD | 17.17% |
| 2016 Q1 | 7.63 Million USD | -20.96% |
| 2016 Q2 | 9.25 Million USD | 21.21% |
| 2016 Q3 | 10.17 Million USD | 9.99% |
| 2016 Q4 | 10.12 Million USD | -0.49% |
| 2016 FY | 37.18 Million USD | 8.65% |
| 2015 FY | 34.22 Million USD | -6.25% |
| 2015 Q4 | 9.65 Million USD | 20.02% |
| 2015 Q3 | 8.04 Million USD | -8.89% |
| 2015 Q2 | 8.83 Million USD | 14.79% |
| 2015 Q1 | 7.69 Million USD | -20.49% |
| 2014 Q3 | 10.36 Million USD | 20.47% |
| 2014 Q1 | 7.86 Million USD | -14.8% |
| 2014 FY | 36.5 Million USD | -7.95% |
| 2014 Q4 | 9.67 Million USD | -6.64% |
| 2014 Q2 | 8.6 Million USD | 9.34% |
| 2013 Q1 | 9.73 Million USD | -7.55% |
| 2013 Q4 | 9.23 Million USD | -12.43% |
| 2013 Q3 | 10.54 Million USD | 3.86% |
| 2013 Q2 | 10.15 Million USD | 4.28% |
| 2013 FY | 39.65 Million USD | 8.07% |
| 2012 FY | 36.69 Million USD | 11.05% |
| 2012 Q4 | 10.52 Million USD | 27.58% |
| 2012 Q3 | 8.25 Million USD | -10.54% |
| 2012 Q2 | 9.22 Million USD | 5.03% |
| 2012 Q1 | 8.78 Million USD | -15.74% |
| 2011 Q2 | 6.75 Million USD | 2.02% |
| 2011 Q3 | 9.24 Million USD | 36.96% |
| 2011 Q4 | 10.42 Million USD | 12.69% |
| 2011 FY | 33.04 Million USD | 42.99% |
| 2011 Q1 | 6.61 Million USD | 2.45% |
| 2010 FY | 23.1 Million USD | 28.51% |
| 2010 Q2 | 5.93 Million USD | 3.72% |
| 2010 Q1 | 5.72 Million USD | 4.53% |
| 2010 Q4 | 6.46 Million USD | 29.45% |
| 2010 Q3 | 4.99 Million USD | -15.91% |
| 2009 Q1 | 3.48 Million USD | -3.81% |
| 2009 Q3 | 4.81 Million USD | 14.46% |
| 2009 Q2 | 4.2 Million USD | 20.58% |
| 2009 Q4 | 5.47 Million USD | 13.71% |
| 2009 FY | 17.98 Million USD | 8.94% |
| 2008 Q3 | 3.88 Million USD | -3.67% |
| 2008 FY | 16.5 Million USD | 49.47% |
| 2008 Q4 | 3.62 Million USD | -6.59% |
| 2008 Q2 | 4.03 Million USD | -18.9% |
| 2008 Q1 | 4.96 Million USD | 366.01% |
| 2007 Q3 | 3.7 Million USD | -18.03% |
| 2007 Q1 | 4.69 Million USD | -66.8% |
| 2007 Q4 | -1.86 Million USD | -150.49% |
| 2007 FY | 11.04 Million USD | -68.96% |
| 2007 Q2 | 4.51 Million USD | -3.92% |
| 2006 FY | 35.58 Million USD | 45.99% |
| 2006 Q3 | 7.97 Million USD | 23.44% |
| 2006 Q4 | 14.14 Million USD | 77.44% |
| 2006 Q1 | 6.99 Million USD | 24.72% |
| 2006 Q2 | 6.46 Million USD | -7.67% |
| 2005 Q1 | 6.4 Million USD | 116.32% |
| 2005 Q2 | 5.48 Million USD | -14.39% |
| 2005 Q3 | 6.88 Million USD | 25.55% |
| 2005 FY | 24.37 Million USD | 75.19% |
| 2005 Q4 | 5.61 Million USD | -18.46% |
| 2004 Q1 | 3.64 Million USD | 3.46% |
| 2004 Q2 | 3.76 Million USD | 3.26% |
| 2004 Q3 | 3.53 Million USD | -6.03% |
| 2004 Q4 | 2.95 Million USD | -16.39% |
| 2004 FY | 13.91 Million USD | 43.93% |
| 2003 Q3 | 2.86 Million USD | 43.19% |
| 2003 Q2 | 2 Million USD | 57.84% |
| 2003 Q4 | 3.52 Million USD | 22.91% |
| 2003 Q1 | 1.26 Million USD | -21.08% |
| 2003 FY | 9.66 Million USD | 13.84% |
| 2002 Q3 | 730 Thousand USD | -87.08% |
| 2002 Q1 | 503 Thousand USD | -50.44% |
| 2002 FY | 8.49 Million USD | 87.21% |
| 2002 Q2 | 5.64 Million USD | 1023.06% |
| 2002 Q4 | 1.6 Million USD | 120.27% |
| 2001 Q2 | 1.55 Million USD | 7.96% |
| 2001 FY | 4.53 Million USD | 145.0% |
| 2001 Q4 | 1.01 Million USD | 96.32% |
| 2001 Q3 | 517 Thousand USD | -66.84% |
| 2001 Q1 | 1.44 Million USD | 640.51% |
| 2000 FY | 1.85 Million USD | -22.88% |
| 2000 Q1 | 627 Thousand USD | 213.5% |
| 2000 Q4 | 195 Thousand USD | -60.04% |
| 2000 Q3 | 488 Thousand USD | -9.8% |
| 2000 Q2 | 541 Thousand USD | -13.72% |
| 1999 Q3 | 1 Million USD | 150.0% |
| 1999 Q1 | 700 Thousand USD | 133.33% |
| 1999 FY | 2.4 Million USD | -17.24% |
| 1999 Q4 | 200 Thousand USD | -80.0% |
| 1999 Q2 | 400 Thousand USD | -42.86% |
| 1998 Q2 | 700 Thousand USD | -56.25% |
| 1998 Q1 | 1.6 Million USD | 6.67% |
| 1998 FY | 2.9 Million USD | -57.97% |
| 1998 Q3 | 300 Thousand USD | -57.14% |
| 1998 Q4 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 3.3 Million USD | 200.0% |
| 1997 Q2 | 1.1 Million USD | 10.0% |
| 1997 FY | 6.9 Million USD | 0.0% |
| 1997 Q1 | 1 Million USD | 0.0% |
| 1997 Q4 | 1.5 Million USD | -54.55% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -1196.683% |
| BrainsWay Ltd. | 31.78 Million USD | -391.952% |
| Envoy Medical, Inc. | 316 Thousand USD | -49383.228% |
| electroCore, Inc. | 16.03 Million USD | -875.465% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -24180.59% |
| IceCure Medical Ltd | 3.22 Million USD | -4742.583% |
| Inogen, Inc. | 315.66 Million USD | 50.463% |
| OrthoPediatrics Corp. | 148.73 Million USD | -5.133% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -6340.157% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -42740.391% |
| MaxCyte, Inc. | 41.28 Million USD | -278.723% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -7908.795% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -141091.715% |
| Orthofix Medical Inc. | 746.64 Million USD | 79.057% |
| PAVmed Inc | 2.45 Million USD | -6277.121% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -594.378% |
| RxSight, Inc. | 89.07 Million USD | -75.541% |
| Sight Sciences, Inc. | 81.05 Million USD | -92.912% |
| SI-BONE, Inc. | 138.88 Million USD | -12.587% |
| TELA Bio, Inc. | 58.45 Million USD | -167.509% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 16.434% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -1033.012% |
| Acutus Medical, Inc. | 7.16 Million USD | -2082.677% |
| Talis Biomedical Corporation | 412 Thousand USD | -37853.155% |
| Spectral AI, Inc. | 18.05 Million USD | -766.011% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -1478.667% |
| CVRx, Inc. | 39.29 Million USD | -297.931% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -16041.843% |
| Bioventus Inc. | 512.34 Million USD | 69.48% |
| Venus Concept Inc. | 76.35 Million USD | -104.792% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -744.725% |
| LivaNova PLC | 1.15 Billion USD | 86.445% |
| 908 Devices Inc. | 50.22 Million USD | -211.308% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 67.576% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -202858.05% |
| NeuroPace, Inc. | 65.42 Million USD | -139.017% |
| LENSAR, Inc. | 42.16 Million USD | -270.854% |
| Apyx Medical Corporation | 52.34 Million USD | -198.701% |
| Cutera, Inc. | 212.36 Million USD | 26.37% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -368.754% |
| BioSig Technologies, Inc. | 18 Thousand USD | -868605.556% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 6.177% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -552.753% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 89.857% |
| Axonics, Inc. | 366.37 Million USD | 57.321% |
| Outset Medical, Inc. | 130.37 Million USD | -19.935% |
| IRIDEX Corporation | 51.86 Million USD | -201.465% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -14.814% |
| IRadimed Corporation | 65.56 Million USD | -138.501% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -13196.514% |
| INVO Bioscience, Inc. | 3.02 Million USD | -5076.73% |
| Telesis Bio, Inc. | 27.5 Million USD | -468.421% |
| Viemed Healthcare, Inc. | 183 Million USD | 14.557% |
| Varex Imaging Corporation | 811 Million USD | 80.719% |
| Quipt Home Medical Corp. | 221.74 Million USD | 29.482% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -127.691% |
| Dynatronics Corporation | 32.53 Million USD | -380.627% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -1701.878% |
| Semler Scientific, Inc. | 68.18 Million USD | -129.331% |
| InMode Ltd. | 492.04 Million USD | 68.221% |
| Bruker Corporation | 2.96 Billion USD | 94.725% |
| Cytosorbents Corporation | 36.34 Million USD | -330.178% |
| DexCom, Inc. | 3.62 Billion USD | 95.683% |
| Align Technology, Inc. | 3.86 Billion USD | 95.951% |
| Viveve Medical, Inc. | 6.42 Million USD | -2333.349% |
| ZimVie Inc. | 457.43 Million USD | 65.816% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 18.987% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -141091.715% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 79.087% |
| Profound Medical Corp. | 7.33 Million USD | -2032.95% |
| Insulet Corporation | 1.69 Billion USD | 90.786% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -24.024% |
| iCAD, Inc. | 17.31 Million USD | -802.916% |
| Nuwellis, Inc. | 8.86 Million USD | -1664.068% |
| Biotricity, Inc. | 12.06 Million USD | -1196.216% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 68.262% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -2420.016% |
| PAVmed Inc. | 2.45 Million USD | -6277.121% |
| BIOLASE, Inc. | 49.16 Million USD | -218.052% |
| Beyond Air, Inc. | 1.15 Million USD | -13391.544% |
| FONAR Corporation | 102.88 Million USD | -51.984% |
| AxoGen, Inc. | 159.01 Million USD | 1.663% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 43.02% |
| Inari Medical, Inc. | 493.63 Million USD | 68.323% |
| UFP Technologies, Inc. | 400.07 Million USD | 60.915% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -840582.796% |
| Tenon Medical, Inc. | 2.92 Million USD | -5240.403% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -2195.451% |
| AdaptHealth Corp. | 3.2 Billion USD | 95.114% |
| Sintx Technologies, Inc. | 2.62 Million USD | -5852.303% |
| NanoVibronix, Inc. | 2.28 Million USD | -6749.19% |
| Quanterix Corporation | 122.36 Million USD | -27.784% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -540.717% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 22.02% |
| TransMedics Group, Inc. | 241.62 Million USD | 35.285% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -1028.678% |
| NeuroMetrix, Inc. | 5.9 Million USD | -2549.648% |
| Hyperfine, Inc. | 11.03 Million USD | -1317.395% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 5.319% |
| Biomerica, Inc. | 5.41 Million USD | -2787.664% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -209.264% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 11.724% |